Abstract:Background Clear cell renal cell carcinoma (ccRCC) tumors have low frequencies of genetic alterations compared with other malignancies, but very high levels of immune cell infiltration and favorable response rates to immunotherapy. Currently, the interplay between specific ccRCC somatic mutations and immune infiltration pattern is unclear. Objective To analyze the associations between common ccRCC somatic mutations and immune cell infiltration patterns within the tumor immune microenvironment (TIME). Design, setting, and participants The study included tumor samples (24 primary and 24 metastatic) from 48 patients with stage IV ccRCC. Targeted sequencing was performed for well-characterized recurrent somatic mutations in ccRCC, with the analysis focusing on the six most common ones: VHL, BAP1, PBRM1, SETD2, TP53, and KDM5C. For each sample, multiplex immunofluorescence (IF) was performed in lymphoid and myeloid panels, for seven regions of interest in three zones (tumor core, stroma, and tumor-stroma interface). IF-derived cellular densities were compared across patients, stratified by their somatic mutation status, using a linear mixed-model analysis. External validation was pursued using RNA-seq enrichment scoring from three large external data sources. Results and limitations Tumors with SETD2 mutations demonstrated significantly decreased levels of FOXP3+ T cells in the tumor core, stroma, and tumor-stroma interface. PBRM1 mutations were associated with decreased FOXP3+ T cells in the tumor core. Primary KDM5C mutations were associated with significantly increased CD206+ macrophage tumor infiltration in the tumor core. A computational method estimating immune cell types in the TIME using bulk RNA-seq data, xCell scoring, failed to validate associations from the IF analysis in large external data sets. A major limitation of the study is the relatively small patient population studied. Conclusions This study provides evidence that common somatic mutations in ccRCC, such as SETD2, PBRM1, and KDM5C, are associated with distinct immune infiltration patterns within the TIME. Patient summary In this study, we analyzed tumor samples from patients with metastatic kidney cancer to determine whether common genetic mutations that arise from the cancer cells are associated with the density of immune cells found within those tumors. We found several distinct immune cell patterns that were associated with specific genetic mutations. These findings provide insight into the interaction between cancer genetics and the immune system in kidney cancer.

Sexual dimorphism in cancer: insights from transcriptional signatures in kidney tissue and renal cell carcinoma

Advances in sex disparities for cancer immunotherapy: unveiling the dilemma of Yin and Yang

Sex Specific Associations in Genome Wide Association Analysis of Renal Cell Carcinoma

The influence of sex hormones on renal cell carcinoma

Sex Dimorphism in the Tumor Microenvironment - from Bench to Bedside and Back

Sex differences in renal cell carcinoma: a single-cell analysis reveals exhausted CD8+ T-cells highly infiltrated in males

Sex-Based Dimorphism of Anticancer Immune Response and Molecular Mechanisms of Immune Evasion

Comprehensive Characterization of Molecular Differences in Cancer Between Male and Female Patients.

Pan-cancer analysis reveals sex-specific signatures in the tumor microenvironment.

Sex-specific survival gene mutations are discovered as clinical predictors of clear cell renal cell carcinoma

Sexual dimorphism in bladder cancer: a review of etiology, biology, diagnosis, and outcomes

An Integrative Study to Investigate Sex-Specific Biomarkers in Bladder Cancer Patients

SexAnnoDB, a knowledgebase of sex-specific regulations from multi-omics data of human cancers

55 Influence of gender on immunosurveillance in a novel mouse model of clear cell renal cell carcinoma

Connecting the Mechanisms of Tumor Sex Differences with Cancer Therapy.

Correlating Immune Cell Infiltration Patterns with Recurrent Somatic Mutations in Advanced Clear Cell Renal Cell Carcinoma

Abstract 3490: Unveiling sex differences in lung adenocarcinoma through multi-omics integrative protein signaling networks

Somatic Mutational Landscape Reveals Mutational Signatures and Significantly Mutated Genes of Cancer Immunotherapeutic Outcome and Sex Disparities

X or Y Cancer: An Extensive Analysis of Sex Differences in Lung Adenocarcinoma

Sex differences in cancer outcomes across the range of eGFR

OncoSexome: the landscape of sex-based differences in oncologic diseases